Phase 1 trial of in situ gene therapy for locally recurrent prostate cancer following radiation therapy failure using sodium/iodide symporter and radioiodine
J.C. Morris, M.D. Endocrinolgy
Brian J. Davis, M.D., Ph.D. Radiation Oncology
Evanthia X. Galanis, M.D. Medical Oncology
Michael M. Lieber, M.D. Urology
Gregory A. Wiseman, M.D. Nuclear Medicine
Stephen J. Russell, M.D., Ph.D. Molecular Medicine
Torrence M. Wilson, M.D. Urology
Mark J. Federspiel, Ph.D. Molecular Medicine